論文

査読有り 国際誌
2014年9月15日

The microRNA-23b/27b/24-1 cluster is a disease progression marker and tumor suppressor in prostate cancer.

Oncotarget
  • Yusuke Goto
  • ,
  • Satoko Kojima
  • ,
  • Rika Nishikawa
  • ,
  • Hideki Enokida
  • ,
  • Takeshi Chiyomaru
  • ,
  • Takashi Kinoshita
  • ,
  • Masayuki Nakagawa
  • ,
  • Yukio Naya
  • ,
  • Tomohiko Ichikawa
  • ,
  • Naohiko Seki

5
17
開始ページ
7748
終了ページ
59
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.18632/oncotarget.2294

Our recent study of microRNA (miRNA) expression signatures in prostate cancer (PCa) has revealed that all members of the miR-23b/27b/24-1 cluster are significantly downregulated in PCa tissues. The aim of this study was to investigate the effectiveness of these clustered miRNAs as a disease progression marker and to determine the functional significance of these clustered miRNAs in PCa. Expression of the miR-23b/27b/24-1 cluster was significantly reduced in PCa tissues. Kaplan-Meier survival curves showed that low expression of miR-27b predicted a short duration of progression to castration-resistant PCa. Gain-of-function studies using mature miR-23b, miR-27b,and miR-24-1 significantly inhibited cell proliferation, migration and invasion in PCa cells (PC3 and DU145). To identify the molecular targets of these miRNAs, we carried out gene expression and in silico database analyses. GOLM1 was directly regulated by miR-27b in PCa cells. Elucidation of the molecular targets and pathways regulated by the tumor-suppressive microRNAs should shed light on the oncogenic and metastatic processes in PCa.

リンク情報
DOI
https://doi.org/10.18632/oncotarget.2294
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/25115396
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202158
ID情報
  • DOI : 10.18632/oncotarget.2294
  • eISSN : 1949-2553
  • PubMed ID : 25115396
  • PubMed Central 記事ID : PMC4202158

エクスポート
BibTeX RIS